Clinical Trials Logo

Aniridia clinical trials

View clinical trials related to Aniridia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04117880 Withdrawn - Aniridia Clinical Trials

A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia

Start date: December 31, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase 2, multicenter, open-label study evaluating the overall systemic and ocular safety profile of ataluren in nonsense mutation aniridia as determined by the incidences of treatment-emergent adverse events (TEAEs) as well as abnormal findings on laboratory assessments, vital signs, physical examinations, ophthalmoscopy, and slit-lamp examination. Participants who complete PTC124-GD-028 ANI (NCT02647359) meet all inclusion and none of the exclusion criteria will be enrolled into this study.